If you invested in Acadia Healthcare and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses »
CLASS PERIOD
02/28/2020 - 10/18/2024
LEAD PLAINTIFF DEADLINE
12/16/2024
RELATED DOCUMENTS
Complaint 10/16/24
STOCK SYMBOL
NASDAQ: ACHC
CONTACT
844-916-0895
[email protected]
The suit, filed in the Middle District of Tennessee, seeks to recover damages for investors who purchased Acadia Healthcare securities between February 28, 2020, and September 26, 2024.
According to the complaint, Acadia Healthcare has engaged in a pattern of detaining patients against their will, even when such detention was not medically necessary. The company is accused of using deceptive tactics to lure patients into its facilities and then holding them captive for financial gain, rather than for their medical treatment.
The lawsuit alleges that Acadia Healthcare's executives were aware of these practices and intentionally misled investors about the company's business model and financial prospects.
The complaint cites a recent investigation by The New York Times that revealed widespread allegations of patient abuse and illegal detention at Acadia Healthcare facilities across the country.
Following the publication of The New York Times investigation on September 1, 2024, the company's stock price plummeted by 4.5%. The decline accelerated on September 27, 2024, when Acadia Healthcare disclosed that it was under investigation by federal authorities. The stock price dropped by a further 16.36% on that day, reflecting investor concerns about the potential legal and financial consequences of the company's misconduct.
FREQUENTLY ASKED QUESTIONS ABOUT THE CASE
- What is the ACHC investigation about?
-
We are investigating whether Acadia may have misled investors about reasons for its revenue growth and about the propriety of its revenue recognition practices.
WHAT SHOULD I DO?
- I worked at ACHC. What should I do?
-
If you were an employee of ACHC, you may have valuable information that could be relevant to the investigation. Hagens Berman is one of the nation’s top whistleblower law firms, and has successfully represented many individuals who come forward with information regarding corporate malfeasance. Under the new SEC Whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, contact Reed Kathrein at 844-916-0895 or [email protected].
- There are multiple law firms participating, do I need to contact all of them?
-
No, you do not need to contact all participating law firms. Generally, class-action investigations and lawsuits are consolidated into a single case to streamline the legal process, and attorneys from only a few law firms are selected to serve in a leadership role on the consolidated case. Hagens Berman has a proven track record of being appointed to leadership roles in complex, multidistrict litigation regarding investor fraud and other consumer rights issues, and your claim will be handled by attorneys who have helped secure approximately $325 billion in class-action settlements on behalf of individuals who have suffered due to corporate malfeasance and the wrongdoing of other powerful institutions.
AM I ELIGIBLE?
- What is the threshold amount to be eligible? What are “substantial” losses?
-
The threshold amount and the definition of "substantial" losses may vary depending on a number of factors specific to the case, including the size of the company, market cap, shares outstanding and who holds them and the damages alleged by the fraud. In general, to be eligible to participate in a class-action lawsuit, you must be able to demonstrate that you suffered financial losses as a result of the alleged wrongdoing and that your losses meet the criteria set by the court or law firm. Fill out the form and submit your losses.
CAN I PARTICIPATE?
- Am I affected? What do I need to do to participate?
-
If you were an investor in ACHC, you may be affected and eligible to participate in the case. To determine your eligibility and potential involvement, fill out the form and submit your losses.
- Can any ACHC investor participate?
-
In most class-action investigations and cases, any investor who meets the eligibility criteria, including purchasing the shares during the relevant period, can participate, regardless of the size of their investment. Fill out the form to find out your rights.
- I bought on a non-U.S. Exchange. Can I participate?
-
No. This investigation only covers shares bought on a U.S. exchange, i.e. NASDAQ or NYSE. Fill out the form to find out your rights.
- Am I included if I still hold my shares, or do I need to sell to participate?
-
Participation is based on purchasing shares during the relevant period, rather than your current holdings. Accordingly, you do not need to sell to participate. Fill out the form to find out your rights.